Beone Medicines Ltd Revenue per Employee (ONC), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Beone Medicines Ltd   (NASDAQ: ONC)
 

Beone Medicines Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 29.69% in the second quarter 2026, year on year to cumulative value of $6,128 million, Beone Medicines Ltd 's revenue per employee grew on a trailing twelve months basis to $ 510,686. The productivity of Beone Medicines Ltd 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 190 other companies have achieved higher revenue per employee. While Beone Medicines Ltd 's total ranking has deteriorated compared to the previous quarter from 1021 to 1693. Beone Medicines Ltd has 12,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ONC Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 29.69 % 35.44 % 32.84 % 41.02 % 41.51 %
Sales per Employee (TTM) $ 510,687 478,155 445,160 414,297 380,078
ONC's Total Ranking # 1693 # 1021 # 533 # 0 # 0
Seq. Revenue Change 12.68 % 1 % 6.12 % 7.38 % 17.67 %

ONC Company Profile >> Back to ONC Efficiency Comparisons >> Compare ONC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 113
Healthcare Sector # 191
Overall Market # 1693

Revenue per Employee Statistics
High Average Low
$ 510,687 $ 161,629 $ 13,144
(Jun 30 2026)   (Sep 30 2018)



Financial Statements
Beone Medicines Ltd 's Revenue MRQ $ 1,705 Millions Visit ONC's Income Statement
Beone Medicines Ltd 's Revenues TTM $ 6,128 Millions Visit ONC's aggregate revenue growth
What are ONC's Sales? Visit ONC's Sales by Segment




Other Ratios
Beone Medicines Ltd 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ONC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ONC's Competitors
Revenue per Employee for ONC's Suppliers
Revenue per Employee for ONC's Customers

You may also want to know
ONC's Sales Growth Rates ONC's Pe Price to earnings ratio ONC's Receivables Turnover Ratio ONC's Stock Quote
ONC's Net Income Growth Rates ONC's Ps Price to Sales ratio ONC's Sales per Employee ONC's Asset Turnover Ratio
ONC's Net Margin ONC's Pb Price to Book ratio ONC's Financial Strength Ratios ONC's Dividend Payout Ratio
Date modified: 2026-09-11T09:58:09+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Carlisle Companies Incorporated  863,898.31 $ 5,097.000  Million 5,900 
Verastem Inc   858,098.04 $ 87.526  Million 102 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Vir Biotechnology Inc   826,231.61 $ 303.227  Million 367 
Immunocore Holdings Plc  822,089.69 $ 430.775  Million 524 
Prothena Corporation Public Limited Company  813,880.60 $ 54.530  Million 67 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Sanuwave Health Inc   798,236.36 $ 43.903  Million 55 
Geron Corporation  791,864.34 $ 204.301  Million 258 
Adma Biologics Inc   789,697.06 $ 510.934  Million 647 
Vericel Corporation  769,605.53 $ 306.303  Million 398 
Cerus Corporation  768,138.89 $ 221.224  Million 288 
Septerna Inc   760,630.77 $ 98.882  Million 130 
Dyadic International Inc   760,447.40 $ 3.802  Million 5 
Transmedics Group Inc   744,396.44 $ 668.468  Million 898 
Aveanna Healthcare Holdings Inc   743,662.86 $ 2,602.820  Million 3,500 
Aytu Biopharma Inc  730,460.53 $ 55.515  Million 76 
Veracyte Inc   721,503.31 $ 544.735  Million 755 
Xtant Medical Holdings Inc   720,185.43 $ 108.748  Million 151 
Harrow Inc   719,172.77 $ 274.724  Million 382 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.